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Abstract
Background: The tailoring of implementation interventions includes the identification of the determinants of, or
barriers to, healthcare practice. Different methods for identifying determinants have been used in implementation
projects, but which methods are most appropriate to use is unknown.
Methods: The study was undertaken in five European countries, recommendations for a different chronic condition
being addressed in each country: Germany (polypharmacy in multimorbid patients); the Netherlands (cardiovascular
risk management); Norway (depression in the elderly); Poland (chronic obstructive pulmonary disease—COPD); and
the United Kingdom (UK) (obesity). Using samples of professionals and patients in each country, three methods
were compared directly: brainstorming amongst health professionals, interviews of health professionals, and
interviews of patients. The additional value of discussion structured through reference to a checklist of
determinants in addition to brainstorming, and determinants identified by open questions in a questionnaire
survey, were investigated separately. The questionnaire, which included closed questions derived from a checklist of
determinants, was administered to samples of health professionals in each country. Determinants were classified
according to whether it was likely that they would inform the design of an implementation intervention (defined as
plausibly important determinants).
Results: A total of 601 determinants judged to be plausibly important were identified. An additional 609
determinants were judged to be unlikely to inform an implementation intervention, and were classified as not
plausibly important. Brainstorming identified 194 of the plausibly important determinants, health professional
interviews 152, patient interviews 63, and open questions 48. Structured group discussion identified 144 plausibly
important determinants in addition to those already identified by brainstorming.
Conclusions: Systematic methods can lead to the identification of large numbers of determinants. Tailoring will
usually include a process to decide, from all the determinants that are identified, those to be addressed by
implementation interventions. There is no best buy of methods to identify determinants, and a combination should
be used, depending on the topic and setting. Brainstorming is a simple, low cost method that could be relevant to
many tailored implementation projects.
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Background
Tailoring implementation interventions to account for the
determinants of practice is a common feature of models
or frameworks for getting evidence into practice [1,2]. In
this paper, we define tailored implementation as imple-
mentation interventions to improve professional practice
that are planned taking account of prospectively identified
determinants of healthcare practice. Determinants are fac-
tors that obstruct or enable changes in targeted profes-
sional behaviours or healthcare delivery processes. These
factors have been referred to as barriers and enablers [3],
barriers and facilitators [4,5], or problems and incen-
tives [6]. For example, in an initiative to implement
guidelines for antihypertensive and cholesterol-lowering
drugs for primary prevention of cardiovascular disease,
structured reflection, a questionnaire for physicians,
and pilot testing were used to identify determinants,
after which a multifaceted intervention was designed,
accounting for the determinants [7]. In a Cochrane sys-
tematic review of 26 randomised trials of this approach,
we found that interventions tailored to prospectively
identified determinants are more likely to improve pro-
fessional practice than no intervention or dissemination
of guidelines. However, the methods used to identify de-
terminants and tailor interventions to address them
were judged to be only poorly developed [8].
Chronic conditions are increasingly common amongst
the ageing populations of many countries worldwide, such
conditions including amongst others diabetes [9], demen-
tia [10], and overweight and obesity [10]. The quality of
care of chronic conditions is variable at best, and therefore
effective approaches are needed for improving care to
minimise the burden of exacerbations and complications
that individuals will have to cope with and health systems
provide care for [11]. If our understanding of the methods
of tailored implementation can be improved, the approach
has potential to help health systems manage the growing
burden of chronic conditions.
Theories of human behaviour [12] or models of practice
change [13] may be used to inform the identification of de-
terminants and provide frameworks for categorising
them. In a review of frameworks for classifying determi-
nants of practice, some of which used behavioural theories
in their development [14], we identified the following
broad categories: guideline factors, health professional fac-
tors, patient factors, professional interactions, incentives
and resources, capacity for organisational change, and so-
cial, political, and legal factors [15].
However, although a variety of methods has been used
to identify determinants of practice, little research has
been undertaken on their validity or feasibility for use in
routine initiatives to improve the quality of care [3,15,16].
Methods currently used to identify determinants include:
brainstorming, focus groups, analysis of performance data,
observations, interviews, and simple or complex ques-
tionnaires [16,17]. These methods may be used with
various groups, including managers, healthcare profes-
sionals, patients or combinations of these, and based in
different settings including primary, secondary, and
community healthcare. The methods may be used indi-
vidually or in combinations, and may focus on the sub-
jective perceptions of patients or professionals, or may
include more objective methods such as observation
[18]. In order to decide on which method, or combin-
ation of methods, should be used under different cir-
cumstances, evaluation of the methods is required. In
particular, it is important to understand how many im-
portant determinants are identified by each method.
This study sought to address this lack of evidence by
evaluating five different methods for identifying determi-
nants of practice. The aim was to investigate the extent to
which the methods identified important determinants and
assess their feasibility in use. In particular, we first aimed to
compare the extent to which brainstorming, health profes-
sional and patient interviews led to the identification of
determinants judged to be important, and secondly to de-
termine the additional value of structured group discus-
sions and open questions in surveys of health professionals
in identifying further determinants. We also investi-
gated the role of closed questions, derived from the
checklist [15] in a questionnaire to samples of health
professionals, in identifying the extent to which selected
determinants were commonly reported. The study was
part of the Tailored Implementation in Chronic Disease
(TICD) programme of research that is seeking to ad-
vance the methods used in tailoring [2].
Methods
Study design
The study took place in five countries, each country
team addressing a different chronic condition, as follows:
UK (obesity), Germany (polypharmacy in multimorbid pa-
tients), Norway depression in the elderly), Netherlands
(cardiovascular risk management), and Poland (COPD).
The countries were selected because the researchers who
developed this EU funded programme of research were
based in them; there was no other rationale for the selec-
tion of countries. The research team in each country se-
lected the condition to be addressed in their country on the
basis of the importance of the condition as they perceived
it, and the existence in their country of practice recommen-
dations or guidelines (see Additional file 1 for information
on the recommendations targeted in each country). Re-
searchers in each of the five participating countries followed
the same protocol.
The study was an evaluation of five methods of identi-
fying determinants (brainstorming, interviews of health
professionals, interviews of patients, structured group
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discussions with health professionals, and questionnaires
for health professionals), in which a direct comparison of
three methods (brainstorming, health professional inter-
views, patient interviews) was undertaken, followed by
evaluation of the additional value of structured group dis-
cussion when undertaken following brainstorming, and
the additional value of questionnaires whose design was
informed by the brainstorming and health professional
and patient interviews, and by reference to the checklist
(see Figure 1) [15]. The study received ethics approval
from the relevant authority in each country (by the NRES
Committee North West - Greater Manchester West for the
UK). In order to establish the feasibility of using the various
methods, in each country, the research team maintained a
diary to record the amount of time spent conducting each
of the methods as well as possible difficulties, concerns and
benefits that were encountered. In addition, interviews were
conducted with a single representative from each of the
participating countries. The interview was conducted by
one of the researcher team (JK or SA), and sought informa-
tion on difficulties or challenges in applying the methods,
any deviations from the recommended procedures for the
methods, and the time taken to conduct and analyse the re-
sults of the methods.
Study population
The study was based in a research centre in each participat-
ing country, and took place in either primary or secondary
care or both, depending on the particular condition and
recommendations being addressed in each country.
Samples of healthcare and public health professionals
and patients were invited to take part. The samples in-
cluded health professionals targeted by the clinical rec-
ommendations (obesity—general practitioners, practice
nurses, dieticians; COPD—general practitioners, practice
nurses, pulmonologists; depression in the elderly—physi-
cians or nurses from primary care and psychiatrists and
specialist nurses from specialist healthcare; polypharmacy
in multimorbidity—GPs and healthcare assistants; cardio-
vascular risk management—GPs and practice staff). Health
professionals were defined as professionals involved in pa-
tient care in the targeted clinical domain. Some participants
may have had other roles, such as team leaders or clinical
teachers, and could also be clinicians or managers. We
aimed to include healthcare and public health professionals
typical of the population that would be targeted by an inter-
vention to improve adherence to guidelines for the selected
condition in each country. In order to identify determinants
experienced by a wide range of professionals, we sought to
ensure that study populations included a mix of male and
female participants with a range of work experience, both
in duration and with a mix of clinicians and managers. A
recently appointed doctor may have different determinants
of practice from a doctor who has been in practice for
many years, and managers may have a different perspective
on the determinants compared to clinicians.
The patients currently had, or had previously had, the
chronic condition of interest. We aimed to include patients
Health 
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Randomise
Brainstorming 
group 1 (B)1
Time 1
Time 2
(after a pause)
Time 3 (after 
brainstorming
Time 4
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Focus groups using 
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Figure 1 Schematic protocol, comparative evaluations.
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at different stages of the condition, different ages, gen-
der and social status. Both health professional and pa-
tient participants were provided with a description of
the clinical recommendations to be implemented and
data on current performance before participating in one
of the study groups.
Methods for identification of determinants
We identified nine commonly used methods for investi-
gating determinants of practice in a literature review, the
methods being: brainstorming by the implementation
team, analysis of performance data, focus groups (health-
care professionals), focus groups (patients), observations
of practice, interviews with healthcare professionals, inter-
views with patients, simple questionnaires and more de-
tailed questionnaires [15]. The review was undertaken as
part of the TICD programme, in parallel with the review
of frameworks and typologies for classifying determinants
used in developing the checklist [15]. We searched Med-
line, CINAHL, and PsychInfo for English language articles
reporting investigations of determinants of practice; stud-
ies involving all types of health professionals and all types
of clinical conditions were included. In the searches, we
used terms such as barrier, obstacle, enabler, facilitator,
classification, taxonomy, ontology, theory, and framework.
The search strategy is reported with the report of the
checklist [15].
An online, two round, Delphi procedure was used to
reach a consensus amongst the investigators from all five
countries on which of these methods should be evaluated
in our study. The research team of each country was asked
to identify five respondents to complete a questionnaire.
The respondents included both researchers interested in
methods of implementation and clinical professionals with
interest in the chronic conditions addressed in our study.
Patients or healthcare managers were not included. Re-
spondents were asked to use a nine-point response format
to indicate the extent to which they believed each method
for identifying determinants possessed the following six at-
tributes (1 = not at all; 9 = completely); the attributes were
feasible, comprehensive, valid, consistent, had reasonable
costs, and were relevant. These questions were developed
in a face-to-face meeting attended by the research collabo-
rators of all five countries. The responses were entered
into a database and the numbers of respondents in each
response category tabulated, this information being fed
back to participants in the second round. The findings of
the second round were presented to a face to face meet-
ing of the research collaborators, at which we reached
consensus on including the following four methods:
structured group discussions with health professionals,
health professional interviews, patient interviews, and
health professional questionnaires. These methods were
most consistently rated by the respondents as having attri-
butes likely to make them useful and feasible in identifying
determinants of practice. In addition, brainstorming was
used as a low cost, low intensity method.
Evaluation of methods
Each country used all five methods to identify the deter-
minants of practice for the chronic condition they were
addressing.
1. Brainstorming with health professionals (two sessions
with between 6 – 10 participants per country),
2. Structured group discussions after brainstorming
with health professionals (two sessions with between
6 – 10 participants per country)
3. Interviews of health professionals (a minimum of 8
participants per country)
4. Interviews with patients (a minimum of 8 patients
per country)
5. Questionnaire survey of health professionals based
on the checklist derived from previous work within
the TICD team (120 participants per country) [15].
Three methods were compared directly with each other
(brainstorming, interviews of health professionals, inter-
views of patients). We also investigated the additional value
if any of undertaking structured group discussions follow-
ing brainstorming, and the additional value of a question-
naire for health professionals designed following the
completion of the other four methods, and devised in the
light of the issues raised by these methods and with refer-
ence to the checklist previously developed in the TICD
programme [15]. This design did not enable us to compare
all five methods with each other, although it allowed us to
contain the numbers of participants that would be required
and mirrored the approach commonly used in studies of
determinants in which combinations of methods are
employed, for example the use of questionnaires to supple-
ment structured reflection and review of other studies in
the study referred to above as an example of investigation
of determinants as part of tailoring implementation [7].
Health professionals were matched and randomly al-
located into one of three groups (see above for numbers
in each group): a group session comprised of an initial
brainstorming phase followed by a structured group dis-
cussion; interviews with health professionals; question-
naire (Figure 2). If, after the randomisation, health
professionals did not wish to participate in the brain-
storming session or interviews then they were asked to
complete the questionnaire. With the exception of the
brainstorming/structured group discussion groups, no
participant completed more than one method. Patients
who agreed to participate were assigned to a group for
interviews of patients. A schematic representation is
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shown in Figure 1. The sample sizes were chosen on
largely pragmatic grounds, to enable both diversity of par-
ticipants and the numbers that would typically be manage-
able in an implementation project. Participants were
recruited through letters or emails sent to eligible individ-
uals or practices. For example, in the UK, emailed invita-
tions to take part were sent to general practices interested
in research in the east midlands region of the country.
Participants randomised to complete the brainstorming
then structured group discussion initially completed a
brainstorming session, and after a short break the group
discussion drew on the checklist as a prompt [15] to struc-
ture the discussion. Interviews with health professionals
and patients were either conducted face to face or by tele-
phone. The interviews were semi-structured in approach;
a single interview guide was used by each country to pro-
duce an interview schedule appropriate for the topic con-
cerned, the checklist being used for additional prompts
during the interviews. All interviews were recorded and
transcribed.
Interview guide on which condition specific interview
schedules were based in each country
1. Please can you tell me about your experience of
caring for people with condition X (professionals);
please can you tell me a little about your experience
of having condition X (patients).
2. Care for patients with condition X does not always
reflect up to date research evidence about the best
way to help patients. This means that patients do
not benefit from the best research evidence. We are
trying to understand why this might be. Can you tell
me, from your experience, what you think
sometimes explains this (i.e., what the barriers to
evidence-based care are)?
3. Are there any other barriers that you think might
be relevant?
4. Which do you think are most important?
5. In your experience, what can help ensure that care
does reflect current best evidence?
6. Are there any other enablers that you think might
be relevant?
7. Which do you think are most important?
8. Thank you very much for your participation in
this study.
The questionnaire was based on the checklist, and was
developed using the results of the interviews and brain-
storming/structured group discussions. The questionnaire
included closed questions with Likert format answers to
the five same statements used in all countries for each of
their recommendations (although translated into the local
language, with a back translation procedure being used to
check stability of interpretation):
Total number of 
hospitals/practices
Randomise
Brainstorming 1 Brainstorming 2 Interviews Questionnaires
n=8 for all countries n=8 for all countries Health Professionals
n=8 for Netherlands, 
United Kingdom and 
Poland
n= 9 for Norway 
n=16 for Germany
Patients
N=4 for United 
Kingdom and 
Norway
N= 8 for Germany, 
Netherlands and 
Poland
n=51 for Norway  
n=67 for Germany
n=73 for 
Netherlands
n=81 for United 
Kingdom
n=242 for Poland
Figure 2 Randomisation of health professionals. The target numbers of participants are indicated for each method.
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1. I feel that this recommendation is feasible and
practical to undertake in my setting.
2. I feel this recommendation fits with my current
practice.
3. I have the knowledge required to implement this
recommendation.
4. The benefits of implementing this recommendation
outweigh the effort of implementing it.
5. I intend to implement this recommendation.
These items were chosen with reference to the checklist,
and the literature undertaken in developing the checklist;
we selected checklist domains that appeared commonly in
the literature as presenting barriers or enablers to imple-
mentation [15]. In addition, country teams included add-
itional questions derived from the checklist that were
judged to be relevant to the clinical topic and setting. Re-
spondents to the questionnaire were asked to indicate the
extent to which they agreed with the determinants above,
using the following five-point scale: fully disagree, dis-
agree, neither agree nor disagree, agree, fully agree. We
combined the ‘agree’ and ‘strongly agree’ responses to
enable calculation of the proportion of respondents re-
garding their ability to implement the recommendation
favourably. Open questions were also included inviting
respondents to highlight any other determinants not
covered by the closed questions.
Measures
The principal measure used to evaluate methods for iden-
tifying determinants was the number of plausibly import-
ant determinants identified by each method. Plausibly
important determinants were defined as ‘a factor for which
there was a consensus in the national research teams that
it would plausibly inform the design of an intervention’.
To inform the design of an intervention, a determinant
should firstly have more than a small effect on perform-
ance, and secondly, it should be possible to address the de-
terminant in the context of a practical implementation
intervention. If a determinant only has a small effect, ad-
dressing it in an implementation intervention will not lead
to much improvement in care. If addressing a determinant
requires an intervention that is not feasible to use, such as
the employment of a large number of additional staff or
the building of new healthcare facilities, we concluded that
we could not plausibly address it. The plausibly important
determinants were, therefore, the determinants to concen-
trate on in tailoring implementation interventions because
we expected that it would be possible to deliver interven-
tions to address them and that improved adherence to the
recommendations might follow. It should be noted that
we did not undertake pilot implementation studies to test
our assessments of the importance of individual determi-
nants; furthermore, the research teams in each country
may have had different interventions available to them,
and an intervention judged not plausible in one country
may have been plausible in another. Plausible importance
is, therefore, a judgment influenced by context, rather
than an absolute property of a determinant. We focus on
the plausibly important determinants in this paper (find-
ings on the determinants not judged plausibly important
are included in Additional file 2).
To identify the plausibly important determinants from
amongst all determinants identified, the following stand-
ard procedure was used by the research teams in each
country (these teams included a mix of researchers with
expertise in health services research and clinical re-
searchers familiar with the clinical field). Each country
was asked to rate the determinants using the following cri-
teria, using a five-point scale:
1. How important is the determinant in influencing
current practice (as judged by the research team):
1 = very low; 5 = very high (i.e., important in
determining practice)
2. To what extent can the determinant be addressed:
1 = very difficult; 5 = very easily (i.e., it is likely that
interventions could be applied to address the
determinant).
A single researcher in each country undertook this,
with discussion with other researchers within countries,
with discussion across countries being used to promote
consistency. In the case of disagreements, final decisions
were taken by the study co-ordinators (JK, SA, RB). Deter-
minants were classified as plausibly important if they
scored at least four for both the above categories. In
addition, the total numbers of unique determinants as well
as the plausibly important determinants for each method
were determined. A unique determinant was defined as a
determinant identified by only one method, determinants
that were not unique being identified by more than one
method. If a method identifies a large number of determi-
nants not identified by any other methods, it may be ne-
cessary to include this method as one to be used in
investigating determinants. The determinants were also
classified by the national research teams according to the
checklist developed in earlier work [15].
Data analysis
The analysis was descriptive only; we did not consider
statistical tests appropriate in view of the diversity of the
topics and countries. The data were loaded into a data-
base, and we first summarised the extent to which the
three initial methods (brainstorming, health professional
interviews, and patient interviews) identified plausibly im-
portant determinants. We simply enumerated the deter-
minants identified by different methods, in the context of
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different countries and different chronic conditions. In this
analysis, the total numbers of plausibly important determi-
nants were calculated, and the numbers identified by each
method alone and those identified by any of the other four
methods included in the study. We then investigated the
number of additional plausibly important determinants
identified by either structured focus groups and or open
questions on the questionnaire. We recorded whether de-
terminants were identified only by one method (defined as
unique determinants), or by more than one method. We
also classified the identified determinants by the domains
of the checklist [15], and calculated the mean score in re-
sponse to the closed questions for the guideline recom-
mendations of each country.
Results
Seventy-two health professionals (between 10 and 18 in
each country) participated in the brainstorming and struc-
tured group discussions, 49 health professionals (between
8 and 16 in each country) took part in health professional
interviews, 32 patients (4 – 8 per country) took part in the
patient interviews, and 514 (67–242) health professionals
completed questionnaires. The number of plausibly import-
ant determinants identified varied according to country
(Table 1). Norway and Germany identified the greatest
number of plausibly important determinants (167 and 155
respectively) while Poland identified only 31. Despite
Germany identifying a large number of plausibly important
determinants, only 11 were classified as unique (i.e., identi-
fied by only one method), although in the other countries a
third or more determinants were classed as unique. The
checklist categories to which the determinants related are
shown in Table 2. Incentives and resources, and individual
health professional factors, were the most common. Rela-
tively few determinants were classified as guideline factors,
capacity for organisational change, or social, political, and
legal factors. This pattern was generally repeated for all five
countries. Table 3 shows the numbers of determinants by
domain identified in the interviews of health professionals
and patients.
Comparison of brainstorming, health professional
interviews and patient interviews
Brainstorming and health professional interviews identi-
fied the greatest number of plausibly important determi-
nants, with brainstorming identifying more than three
times as many determinants as patient interviews (Table 4).
Of the unique determinants, 51.8% were identified by
brainstorming, 34.5% by health professional interviews,
and 13.7% by patient interviews. In all countries, more
than half the determinants were identified by more than
one method, although more than one third were classed
as unique in Norway, the Netherlands and the UK.
Additional value of the structured focus groups and
questionnaire open questions
Both structured group discussions following brainstorming,
and, to a lesser extent, open questions in a survey, identified
additional plausibly important determinants (Table 5). Both
methods contributed unique determinants, although rela-
tively few were identified by the open questions.
Closed questions for each recommendation
Five closed questions were used per recommendation in
each country. The mean score for all five questions per
country are summarised in Table 6. Respondents indicated
that most of the recommendations were implementable,
with the exception of recommendation one for the UK
and recommendations three and six for Norway.
Feasibility
Recruiting participants
Successful recruitment of healthcare professionals and pa-
tients for interviews varied between the participating coun-
tries, but was assisted by the presence of networks of
practices interested in research, as in Germany and the UK.
In some instances, the recruitment of GPs proved dif-
ficult due to their busy workloads, and the absence of fi-
nancial incentives seemed to further contribute to the
difficulty in those countries in which reimbursement for
professionals’ time was not available. Moreover, paper
based invitations to participate were less effective than
Table 1 Comparison between countries of determinants identified by one method only (unique) and determinants
identified by more than one method, in each country
United Kingdom
(obesity)
Norway (depression
in the elderly)
Netherlands
(cardiovascular
risk management)
Poland
(COPD)
Germany (polypharmacy
in multimorbidity patients)
Total
Unique determinants – Not
identified by any other method
43 (39.4) 77 (46.1) 62 (44.6) 9 (29.0) 11 (7.1) 202 (33.5)
Identified by at least one
other method
66 (60.6) 90 (53.9) 77 (55.4) 22 (71.0) 144 (92.1) 399 (66.5)
Total 109 (100) 167 (100) 139 (100) 31 (100) 155 (100) 601 (100)
N (%).
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electronic communications. The Norwegian team faced
difficulties recruiting patients who were able to discuss
their illness and how it related to the recommendation,
possibly because of cognitive difficulties or because the
recommendations or the task were not presented to the
patients in an understandable way.
Interviews of professionals and patients
Generally positive attitudes were expressed by each of the
participating teams towards the use of interviews as they
appeared to yield more in-depth findings than that of
questionnaires. Some felt that those healthcare profes-
sionals who agreed to participate were the most enthused
and engaged with the topic area and so provided the most
significant feedback. There were significant time costs as-
sociated with the transcription and analysis of each of the
interviews as well as the time implications with the inter-
views themselves. The diaries showed that interviews re-
quired the most time of all the methods.
Brainstorming and structured group discussions
The methods yielded a wide array of issues associated with
each of the chronic conditions, and they informed the
interview schedule design, which enabled the key topics to
be further explored and reinforce the opinions expressed
in the group sessions. Some of the participants were
familiar with the methodology, and, in the opinion of
some research teams, these methods together yielded
the most important plausible determinants. However,
some felt the initial silent phase in the brainstorming
groups was artificial and often informal discussions
broke out regardless of protocol. The transcription and
analysis of the group sessions took time, but given that
each team ran only two group sessions in comparison to
several interviews, the time costs were not as large as
with the interviews.
Questionnaires
Each of the participating countries experienced significant
problems with the questionnaire, and arguably out of each
of the methods it was regarded as the most problematic.
Firstly, there were problems in achieving adequate response
rates, exacerbated by the use of paper based questionnaires
when necessary instead of electronic questionnaires. The
Norwegian team was unable to obtain email addresses from
various healthcare professional organisations due to data
protection issues, and so was reliant on paper-based ques-
tionnaires. The paper based questionnaires together with
follow up reminder letters were costly.
Discussion
Main findings and interpretation
In this study, we investigated different methods for
identifying those determinants of practice that may be
addressed in tailored implementation interventions,
which we have termed plausibly important determi-
nants. Each of the methods was able to identify such de-
terminants, although brainstorming and interviews with
health professionals identified the greatest number of
determinants in all countries. The open questions of the
questionnaire and interviews with patients identified
fewer determinants. Although the number of determi-
nants identified by interviews with patients was rela-
tively low (in comparison to other methods) nearly a
third were classified as unique. The findings suggest
that there is no single best method for identifying deter-
minants, but that a combination of methods should be
Table 2 Plausibly important determinants identified by all 5 methods and classified by checklist domain [15]
Domain United Kingdom Norway Netherlands Poland Germany Total
1. Guideline Factors 16 24 8 2 3 53
2. Individual Health Professional Factors 31 51 18 6 36 142
3. Patient Factors 18 36 18 10 15 97
4. Professional Interactions 6 14 28 0 33 81
5. Incentives and Resources 28 30 49 13 41 161
6. Capacity for Organisational Change 4 12 16 0 2 34
7. Social, Political and Legal Factors 6 0 2 0 12 20
8. Miscellaneous 0 0 0 0 13 13
Table 3 The numbers of plausibly important
determinants identified by interviews of health
professionals or patients, by domain
Domain Health professionals Patients
1. Guideline Factors 2 2
2. Individual Health
Professional Factors
34 13
3. Patient Factors 13 12
4. Professional Interactions 14 6
5. Incentives and Resources 30 8
6. Capacity for Organisational Change 3 0
7. Social, Political and Legal Factors 4 3
8. Miscellaneous 4 0
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considered, chosen depending on the guideline or recom-
mendations being implemented. Thus, although the large
number of unique and plausibly important determinants
identified by brainstorming suggests that it could be used
as a relatively quick and inexpensive method to identify a
large number of determinants, if patients or health profes-
sionals are particularly affected by the targeted recommen-
dations, interviews of patients and health professionals
should be undertaken as well. Therefore, a combination of
brainstorming, and health professional and patient inter-
views may be adequate in the case of many chronic condi-
tions. In view of the effectiveness of the structured group
discussions in generating additional determinants, the use
of the checklist or similar prompting mechanism is likely
to be helpful.
It is striking how many determinants were identified in
each country. The numbers per country did vary, from
167 in Norway (depression in the elderly) to 31 in Poland
(COPD), but it is not clear whether this variation is
accounted for by the conditions addressed, or whether the
perceptions of professionals and patients and their pro-
pensity to report problems in care differ between coun-
tries. The finding does suggest, however, that tailored
implementation interventions should not be assumed to
be transferrable between conditions or countries.
We used a systematic approach and several different
methods, and identified 601 plausibly important determi-
nants in total (a mean of 120 per country). This finding has
implications for implementation strategies; if there are so
many determinants of practice that should be accounted
for, the process of tailoring will potentially be challenging.
For example, it would be difficult, if possible at all, to ad-
dress 120 determinants in any implementation program.
An alternative might be addressing determinants at the
level of the individual, since the number of determinants
relating to an individual health professional is likely to be
fewer, but the problem of large numbers of determinants
will recur if several individuals are involved. In our study,
we eliminated determinants that we judged were unlikely
to be important, or not amenable to change through an
implementation strategy (see Additional file 2). It is pos-
sible that our decisions on some determinants were wrong;
the process for selecting the most important determinants
to address require developing and testing in future work.
Strengths and limitations
To our knowledge, this is the first study to compare the
effectiveness of different methods of identifying determi-
nants of practice to inform tailoring, in different chronic
conditions in different countries. A standard protocol was
followed in each country, and we believe the procedures
followed in each country were broadly consistent. How-
ever, there may have been some variation; for example,
randomisation of participants to study groups was under-
taken separately in each country without central control,
and therefore some inconsistency may have crept in. Like-
wise, the classification of determinants as plausibly im-
portant was undertaken within each participating country,
leading to opportunities for some inconsistency.
We are unable to judge whether or not all the determi-
nants have been identified, since there is no gold standard
method against which to compare the methods used in this
study. It is not possible to determine whether the determi-
nants we have identified are genuinely the most important
to address in implementing change, and we cannot be cer-
tain that our assessments of the importance of the determi-
nants and the extent to which they are amenable to change
are valid. We will, however, assess the effectiveness of the
tailored interventions by clustered trials in each country,
and explore the validity of the determinants addressed
through process evaluations of the trials [19-24] of the
plausibly important determinants identified, the majority
Table 4 A comparison of three methods for identifying plausibly important determinants (brainstorming, health
professional interviews and patient interviews)
Method Number of determinants not identified by
any other method (unique determinants)
Number of determinants Identified
by at least one other method*
Total
Brain Storming amongst health professionals 72 (37.2) 122 (62.8) 194 (100)
Health Professional Interviews 48 (31.6) 104 (68.4) 152 (100)
Patient Interviews 19 (30.2) 44 (69.8) 63 (100)
*other methods include brainstorming, structured focus groups, open questionnaire, patient interviews, professionals’ interviews.
N (%).
Table 5 Additional value of structured focus groups and open questions on questionnaire in identifying plausibly
important determinants
Method Not identified by
any other method
Number Identified by at
least one other method
Total
Structured Focus Group in addition to Brainstorming 52 (36.1) 92 (63.9) 144 (100)
Open questions in addition to the questionnaire 10 (20.8) 38 (79.2) 48 (100)
N (%).
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Table 6 Mean percentage of responses either agree or strongly agree (standard deviation) to the five questions of the closed questionnaire
UK Norway Netherlands Poland Germany
Rec. Mean (SD) Rec. Mean (SD) Rec. Mean (SD) Rec. Mean (SD) Rec. Mean (SD)
Determine degree
of overweight
72.4% (+10.2) Social contact 80.8% (+15.2) BP control in
raised risk
83.0% (+5.8) Smoking cessation counseling 83.4% (+4.8) Structured medication
counseling
66.6% (+19.7)
Assess willingness
to change
71.1% (+6.8) Collaborative care 59.8% (+17.3) BP control in
cardiovascular disease
87.7% (+3.5) Grade breathless 86.3% (+5.4) Use of medication
schedules
92.2% (+6.1)
Offer management 78.8% (+4.4) Depression care manager 51.0% (+28.3) Cholesterol control
in raised risk
78.9% (+6.1) Information for the patient 87.9% (+5.3) Avoid inadequate
medication
59.4% (+15.2)
Consider referral 53.1% (+24.9) Counseling 72.2% (+11.5) Cholesterol control in
cardiovascular disease
88.2% (+2.1) Inhaler use education 91.8% (+4.2)
Mild depression 58.4% (+16.4) Lifestyle advice 81.4% (+2.5)
Severe depression,
recurrent or chronic
depression, dysthymia
47.4% (+21.5) Assess risk in chronic
kidney disease
75.1% (+6.4)
Rec = recommendations.
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were classified as individual health professional factors and
incentives and resources. Relatively few were classified as
capacity for organisational change, and social, political, and
legal factors, which would be difficult to address in the
context of an implementation intervention [14]. The ques-
tionnaire was designed in the light of the findings of the in-
terviews since we could not be blinded to the findings of
the interviews. We were unable, therefore, to directly com-
pare the ability of questionnaires to elicit determinants
with the other methods.
Comparison with literature
Despite a high number of studies on barriers for change,
we have identified little other research into different
methods of identifying determinants. Bosch et al. [17] in-
vestigated the methods used in 20 quality improvement
studies, finding that a variety of methods were used. Most
were qualitative methods such as interviews of profes-
sionals or patients, and it was not possible to recommend
which methods should generally be employed.
Practice implications
This study has advanced understanding of determinants of
practice by showing that many can be identified by making
explicit the process by which identified determinants are
assessed and those most important to address selected, and
by showing that there is no overall ‘best buy’ of method for
identifying determinants. Different methods tend to lead to
the identification of rather different sets of determinants,
and consequently use of a combination of methods is more
likely to lead to the identification of the key plausibly im-
portant determinants than use of any single method alone.
The nature of the guideline recommendations being imple-
mented should be taken into account, as patients or health
professionals may have particular views in relation to some
recommendations. Our findings suggest that brainstorming
with a structured group discussion (using a checklist to
prompt suggestions) and one additional method (e.g., inter-
views of health professionals, interviews of patients) should
identify a high proportion of determinants in relation to
the costs and time involved in conducting each method.
Once the determinants of practice to be targeted have
been identified, interventions are required to address
them. This step in the process of tailored implementa-
tion is not considered in this paper. However, our find-
ings do have implications for the process of tailoring
implementation to account for determinants. It is diffi-
cult to devise an intervention to address each and every
determinant. Tailoring is therefore likely to require a fur-
ther set of choices to be made about which determinants
should be prioritised, or which interventions may be
likely to address, at least in part, several determinants.
In the TICD research programme, a study is underway
to investigate approaches to tailoring [2].
Conclusions
Tailored implementation is a complex approach, a key step
of which is the identification of determinants of practice.
This step involves selecting which methods to use and de-
ciding which of the determinants are important to address.
A selection of methods is available for identifying determi-
nants, and in most implementation initiatives, a mix of
methods should be used in order to identify most of the
important determinants. Because a large number of deter-
minants are likely to be identified, a process is required to
extract from the many those few that can be practically
addressed in implementation interventions, with conse-
quent improved adherence to recommendations. In the
absence of such a process, implementation risks remaining
an often ‘hit or miss affair,’ with the impact on practice im-
provement being unpredictable and inadequate. The de-
velopment and evaluation of systematic approaches to
select the most important determinants is now required.
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